Session » Abstracts: RA – Treatments I: Novel RA Treatments & Mechanisms of Action
- 4:00PM-5:30PM
-
Abstract Number: 0837
A Randomized, Double-Blind, Sham-Controlled, Clinical Trial of Auricular Vagus Nerve Stimulation for the Treatment of Active Rheumatoid Arthritis
- 4:00PM-5:30PM
-
Abstract Number: 0835
Abatacept in Individuals at Risk of Developing Rheumatoid Arthritis: Results from the Arthritis Prevention in the Pre-clinical Phase of RA with Abatacept (APIPPRA) Trial
- 4:00PM-5:30PM
-
Abstract Number: 0839
Efficacy and Safety of Nipocalimab in Patients with Moderate to Severe Active Rheumatoid Arthritis (RA): The Multicenter, Randomized, Double-blinded, Placebo-controlled Phase 2a IRIS-RA Study
- 4:00PM-5:30PM
-
Abstract Number: 0840
Head-to-Head Comparison of TLL-018 and Tofacitinib in Patients with Active Rheumatoid Arthritis: Final Results from a Phase IIa Study
- 4:00PM-5:30PM
-
Abstract Number: 0838
Infusion of Etanercept into the Peripheral Lymphatics Significantly Reduces Disease Activity in Rheumatoid Arthritis Patients with Inadequate Response to Subcutaneous Injections
- 4:00PM-5:30PM
-
Abstract Number: 0836
Vagotomy and Subsequent Risk of Rheumatoid Arthritis and Osteoarthritis: A Danish Register-Based Cohort Study